| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-10 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-07 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-07 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.19 | 7e-07 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 7e-07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.21 | 7e-07 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |